Insider trading

Period: 120 months Stock: ISRG Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

280 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

280 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

280 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

280 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
280 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
280 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

280 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
27 Feb 2024
Curet Myriam EVP & Chief Medical Officer
Sold at will
$325.79K 843 at 386.46
73.9%
Sold half or more
14 Nov 2023
DeSantis Robert EVP & Chief Strategy & Corp Op
Sold at will 2×
$251.43K 867 at 290.00
10.7%
Not planned
24 Oct 2023
DeSantis Robert EVP & Chief Strategy & Corp Op
Sold at will 3×
$303.57K 1,110 at 273.49
13.3%
Not planned
31 Jul 2023
GUTHART GARY S CEO · indirect
Sold at will 2×
$1.62M 4,960 at 325.89
13.3%
Not planned
28 Jul 2023
Sold at will
$16.44M 50,314 at 326.76
74.5%
Sold half or more
25 Jul 2023
DeSantis Robert EVP & Chief Strategy & Corp Op
Sold at will 6×
$819.46K 2,535 at 323.26
25.9%
Not planned
14 Jun 2023
MOHR MARSHALL Executive VP Global Business S
Sold at will
$3.66M 11,250 at 325.00
31.8%
Not planned
14 Jun 2023
DeSantis Robert EVP & Chief Product Officer
Sold at will
$793.98K 2,443 at 325.00
25.2%
Not planned
14 Jun 2023
BARRATT CRAIG H Director
Sold at will
$505.80K 1,567 at 322.78
100%
Sold half or more
1 May 2023
BARRATT CRAIG H Director
Sold at will
$612.00K 2,000 at 306.00
100%
Sold half or more
28 Apr 2023
RUBASH MARK J Director
Sold at will 7×
$2.20M 7,323 at 300.00
32.1%
Not planned
24 Apr 2023
Rosa David J. EVP Chief Strategy & Growth Of
Sold at will
$12.20M 40,764 at 299.20
20.7%
Not planned
21 Apr 2023
Rosa David J. EVP Chief Strategy & Growth Of
Sold at will
$12.16M 40,800 at 297.92
22.3%
Not planned
21 Apr 2023
RUBASH MARK J Director
Sold at will 20×
$2.93M 9,818 at 297.93
39.6%
Not planned
21 Apr 2023
Curet Myriam EVP & Chief Medical Officer
Sold at will 4×
$2.88M 9,623 at 299.76
96.7%
Sold half or more
21 Apr 2023
DeSantis Robert EVP & Chief Product Officer
Sold at will 7×
$2.57M 8,623 at 297.92
55.0%
Sold half or more
21 Apr 2023
BARRATT CRAIG H Director
Sold at will 3×
$1.79M 6,000 at 297.92
100%
Sold half or more
21 Apr 2023
Widman Fredrik VP Corporate Controller
Sold at will
$187.66K 630 at 297.87
22.0%
Not planned
1 Mar 2023
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$286.27K 1,253 at 228.47
39.1%
16 Feb 2023
DeSantis Robert EVP & Chief Product Officer
Sold, plan not stated
$474.56K 1,971 at 240.77
23.6%
16 Feb 2023
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$270.63K 1,124 at 240.77
77.5%
Sold half or more
16 Feb 2023
Widman Fredrik VP Corporate Controller
Sold, plan not stated
$27.93K 116 at 240.77
6.7%
13 Feb 2023
MOHR MARSHALL Executive VP Global Business S
Sold, plan not stated
$8.17M 33,249 at 245.61
61.6%
Sold half or more
13 Feb 2023
Widman Fredrik VP Corporate Controller
Sold, plan not stated
$321.64K 1,307 at 246.09
46.7%
6 Feb 2023
Rosa David J. EVP Chief Strategy & Growth Of
Sold, plan not stated
$11.28M 45,025 at 250.53
26.4%
27 Jan 2023
DeSantis Robert EVP & Chief Product Officer
Sold, plan not stated 2×
$407.25K 1,629 at 250.00
19.4%
8 Nov 2022
Johnson Amal M Director
Sold, plan not stated
$1.53M 6,375 at 239.36
36.2%
1 Nov 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated 2×
$2.00M 8,000 at 250.06
97.4%
Sold half or more
21 Oct 2022
GUTHART GARY S President & CEO
Sold, plan not stated
$9.32M 44,203 at 210.84
65.5%
Sold half or more
21 Oct 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated 2×
$1.68M 8,000 at 209.78
97.4%
Sold half or more
8 Sep 2022
Johnson Amal M Director
Sold, plan not stated
$1.34M 6,375 at 210.76
36.2%
15 Aug 2022
Ladd Amy L Director
Sold, plan not stated
$142.22K 600 at 237.03
45.5%
3 Aug 2022
Johnson Amal M Director
Sold, plan not stated
$1.52M 6,375 at 238.04
36.2%
27 Jul 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$2.03M 9,000 at 225.00
97.6%
Sold half or more
26 Jul 2022
GUTHART GARY S President & CEO
Sold, plan not stated
$17.18M 79,412 at 216.30
59.3%
Sold half or more
26 Apr 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$1.52M 6,000 at 252.51
94.3%
Sold half or more
26 Apr 2022
DeSantis Robert EVP & Chief Product Officer
Sold, plan not stated 4×
$407.65K 1,611 at 253.04
20.2%
1 Mar 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$579.92K 2,000 at 289.96
84.7%
Sold half or more
16 Feb 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$716.14K 2,478 at 289.00
87.3%
Sold half or more
25 Jan 2022
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated 2×
$1.58M 6,000 at 263.94
95.5%
Sold half or more
25 Jan 2022
DeSantis Robert EVP & Chief Product Officer
Sold, plan not stated 4×
$368.91K 1,410 at 261.64
56.4%
Sold half or more
24 Nov 2021
Johnson Amal M Director
Sold, plan not stated
$2.50M 7,500 at 333.73
41.3%
25 Oct 2021
MOHR MARSHALL Executive VP & CFO
Sold, plan not stated
$6.95M 20,475 at 339.20
100%
Sold half or more
22 Oct 2021
LEVY ALAN J Director
Sold, plan not stated 2×
$2.55M 7,500 at 339.64
23.6%
22 Oct 2021
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated
$2.04M 6,000 at 339.64
95.5%
Sold half or more
22 Oct 2021
Samath Jamie SVP of Finance
Sold, plan not stated 6×
$510.51K 1,503 at 339.66
66.4%
Sold half or more
22 Oct 2021
DeSantis Robert EVP & Chief Product Officer
Sold, plan not stated 4×
$344.51K 1,014 at 339.75
48.1%
9 Sep 2021
Curet Myriam EVP & Chief Medical Officer
Sold, plan not stated 2×
$4.60M 4,250 at 1,082.54
97.8%
Sold half or more
9 Sep 2021
RUBASH MARK J Director
Sold, plan not stated 5×
$1.30M 1,196 at 1,083.16
19.9%
26 Aug 2021
DeSantis Robert EVP & Chief Product Officer
Sold, plan not stated
$416.10K 397 at 1,048.12
52.2%
Sold half or more
Showing 1–50 of 280. Page 1 of 6 Older →